To confirm whether IGFBP7 expression is associated with the clinical response to IFN-α/5-FU therapy, HCC samples of 30 patients who underwent IFN-α/5-FU therapy postoperatively were immunohistochemically stained for IGFBP7 expression. Here, IGFBP7 is linked to hepatocellular carcinoma.